- Home
- TXMD vs BNZI Comparison
TXMD vs BNZI Comparison
Compare TXMD & BNZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- BNZI
- Stock Information
- Founded
- TXMD 2008
- BNZI 2016
- Country
- TXMD United States
- BNZI United States
- Employees
- TXMD N/A
- BNZI N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- BNZI
- Sector
- TXMD Health Care
- BNZI
- Exchange
- TXMD Nasdaq
- BNZI Nasdaq
- Market Cap
- TXMD 12.3M
- BNZI 11.5M
- IPO Year
- TXMD N/A
- BNZI N/A
- Fundamental
- Price
- TXMD $1.23
- BNZI $2.07
- Analyst Decision
- TXMD
- BNZI Strong Buy
- Analyst Count
- TXMD 0
- BNZI 1
- Target Price
- TXMD N/A
- BNZI $30.00
- AVG Volume (30 Days)
- TXMD 506.6K
- BNZI 479.1K
- Earning Date
- TXMD 11-12-2025
- BNZI 11-13-2025
- Dividend Yield
- TXMD N/A
- BNZI N/A
- EPS Growth
- TXMD N/A
- BNZI N/A
- EPS
- TXMD N/A
- BNZI N/A
- Revenue
- TXMD $2,559,000.00
- BNZI $9,021,543.00
- Revenue This Year
- TXMD $427.09
- BNZI $230.60
- Revenue Next Year
- TXMD N/A
- BNZI $38.19
- P/E Ratio
- TXMD N/A
- BNZI N/A
- Revenue Growth
- TXMD 156.93
- BNZI 107.94
- 52 Week Low
- TXMD $0.70
- BNZI $2.08
- 52 Week High
- TXMD $2.44
- BNZI $28.90
- Technical
- Relative Strength Index (RSI)
- TXMD 59.44
- BNZI 34.74
- Support Level
- TXMD $1.20
- BNZI $2.40
- Resistance Level
- TXMD $1.37
- BNZI $3.13
- Average True Range (ATR)
- TXMD 0.12
- BNZI 0.28
- MACD
- TXMD 0.02
- BNZI -0.11
- Stochastic Oscillator
- TXMD 29.85
- BNZI 0.55
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About BNZI Banzai International Inc.
Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling marketing, sales and customer engagement outcomes. The company has two reportable operating segments, Banzai Operating and OpenReel. The company's segments deliver SaaS tools that leverage data, analytics, and AI to provide marketing and sales solutions for business of all size. it derives maximum revenue from Banzai Operating segment. Geographically, it operates in Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific.